SPONSOR
Akeso
Total Trials
8
Recruiting
8
Phases
Phase 2, Phase 1, Phase 2, Phase 1, Phase 3
Conditions studied: Hepatocellular Carcinoma (HCC)Platinum-sensitive Ovarian CancerHepatocellular CarcinomaGastric Adenocarcinoma and Gastroesophageal Junction AdenocarcinomaSolid Tumor, AdultSolid CancerPancreatic Cancer
NCT07052253 Phase 2
Recruiting
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.
Hepatocellular Carcinoma (HCC)
NCT06686030 Phase 2
Recruiting
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
Platinum-sensitive Ovarian Cancer
NCT06530251 Phase 1, Phase 2
Recruiting
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
NCT04982276 Phase 1, Phase 2
Recruiting
A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma
Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
NCT05689853 Phase 1, Phase 2
Recruiting
Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors
Solid Tumor, Adult
NCT06730386 Phase 1
Recruiting
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
Solid Cancer
NCT06953999 Phase 3
Recruiting
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
Pancreatic Cancer
NCT07114315 Phase 2
Recruiting
A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer
Pancreatic Cancer